Large-scale testing (Phase 3)UnknownNCT05216562
What this trial is testing
Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients
Who this might be right for
SARS-CoV2 Infection
Dermama Bioteknologi Laboratorium 60